PHS
INGN icon

PFM Health Sciences’s Inogen INGN Stock Holding History

PFM Health Sciences’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-141,077
Closed -$9.42M – 86
2019
Q2 		$9.42M Buy
+141,077
New +$10.7M 0.18% 76
2018
Q4 		– Sell
-143,625
Closed -$35.1M – 109
2018
Q3 		$35.1M Buy
+143,625
New +$33.2M 0.51% 70
2018
Q2 		– Sell
-1,657
Closed -$204K – 120
2018
Q1 		$204K Sell
1,657
-90,172
-98% -$11M ﹤0.01% 93
2017
Q4 		$10.9M Sell
91,829
-149,228
-62% -$16.4M 0.26% 74
2017
Q3 		$22.9M Buy
+241,057
New +$23.2M 0.45% 64
2017
Q2 		– Sell
-61,951
Closed -$4.8M – 99
2017
Q1 		$4.8M Buy
+61,951
New +$4.29M 0.12% 92

Other funds holding INGN

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PFM Health Sciences's INGN Position: Q3 2019 in Review

PFM Health Sciences sold out of Inogen (INGN) in Q3 2019, closing a stake of 141,077 shares — an estimated $9.42M sold.

PFM Health Sciences first reported a position in INGN in Q1 2017 and held it in 6 quarters. The position peaked at $35.1M in Q3 2018. 176 funds tracked by Wall St. Rank hold INGN as of Q3 2019.

  • PFM Health Sciences reported no remaining Inogen position as of Q3 2019 after selling out during the quarter.
  • PFM Health Sciences sold 141,077 Inogen shares in Q3 2019, an estimated $9.42M.
  • PFM Health Sciences first reported a position in Inogen in Q1 2017 and held it in 6 quarters.
  • PFM Health Sciences's Inogen position peaked at $35.1M in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Inogen as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.